Marie Garinot

Title: **Marie Garinot: Innovator in Vaccine Formulations**

Introduction

Marie Garinot is a notable inventor based in Lyons, France, recognized for her significant contributions to the field of immunology through her patented innovations. With a total of two patents to her name, she has developed groundbreaking vaccine formulations that enhance the efficacy and safety of immunization practices.

Latest Patents

Marie Garinot's latest patents reflect her commitment to advancing vaccine technology. One of her key inventions is an immunogenic formulation comprising linear or branched polyacrylic acid polymer adjuvants. This innovative approach utilizes a newly applied non-crosslinked polyacrylic acid polymer adjuvant, which can be combined with various immunogens to create safe and effective vaccines for a diverse range of target animals, including humans, felines, canines, and more.

Her second patent features a vaccine composition that incorporates aluminum hydroxide nanoparticles as an adjuvant. This formulation is characterized by the presence of sterile-filterable nanoparticles made up of pseudo-boehmite and polyacrylate, providing a robust platform for maintaining vaccine efficacy.

Career Highlights

Marie Garinot has worked at Sanofi Pasteur Inc. and Sanofi Pasteur SA, where she has played a vital role in the development of vaccine technologies. Her research and innovations have positioned her as a leading figure in immunology, contributing to advancements that are crucial to public health.

Collaborations

Throughout her career, Marie has collaborated with esteemed colleagues, including Jean Haensler and Yannick Mathieu. These partnerships have enhanced her research capabilities and have led to significant advancements in the development of novel vaccine formulations.

Conclusion

Marie Garinot's innovative work in the field of immunology serves as an inspiration to aspiring inventors and researchers. Her contributions through her patents highlight the importance of advancing vaccine technology in efforts to promote health and well-being across various animal populations. Through her continued dedication, she remains a prominent figure in the field of vaccine development.